RSI low/high Values: [ 20 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ACLX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Arcellx, Inc. stock price down 2.13% on Tuesday
(Updated on Apr 30, 2024)

Sell candidate since Apr 19, 2024 Loss -3.16% PDF

The Arcellx, Inc. stock price fell by -2.13% on the last day (Tuesday, 30th Apr 2024) from $51.11 to $50.02. During the last trading day the stock fluctuated 3.44% from a day low at $49.88 to a day high of $51.60. The price has fallen in 6 of the last 10 days and is down by -9.42% for this period. Volume has increased on the last day by 84 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 445 thousand shares were bought and sold for approximately $22.27 million.

Given the current short-term trend, the stock is expected to fall -13.62% during the next 3 months and, with a 90% probability hold a price between $43.21 and $59.26 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ACLX Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Arcellx, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $51.96 and $61.97. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, March 20, 2024, and so far it has fallen -31.94%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Arcellx, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.72 between high and low, or 3.44%. For the last week, the stock has had daily average volatility of 3.93%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ACLX) For The Upcoming Trading Day Of Wednesday 1st

For the upcoming trading day on Wednesday, 1st we expect Arcellx, Inc. to open at $50.50, and during the day (based on 14 day Average True Range), to move between $47.46 and $52.58, which gives a possible trading interval of +/-$2.56 (+/-5.12%) up or down from last closing price. If Arcellx, Inc. takes out the full calculated possible swing range there will be an estimated 10.23% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $51.65, some $1.63 (3.26%) from the current price of $50.02, our system finds the risk reward not very attractive.

Is Arcellx, Inc. stock A Buy?

Arcellx, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -6.535 Strong Sell Candidate Unchanged

Predicted Opening Price for Arcellx, Inc. of Wednesday, May 1, 2024

Fair opening price May 1, 2024 Current price
$50.50 ( 0.96%) $50.02

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ACLX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 52.21 4.38 %
R2 51.56 3.08 %
R1 51.15 2.27 %
Current price: 50.02
Support S1 49.84 -0.353 %
S2 49.44 -1.16 %
S3 48.78 -2.47 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 62.01 23.97 %
R2 54.50 8.96 %
R1 51.65 3.26 %
Current price 50.02
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Arcellx, Inc. Stock and on which exchange is it traded?
The symbol for Arcellx, Inc. is ACLX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Arcellx, Inc. Stock?
Arcellx, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Arcellx, Inc. Stock?
Arcellx, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Arcellx, Inc. Stock.

What's the current price of Arcellx, Inc. Stock?
As of the end of day on the Apr 30, 2024, the price of an Arcellx, Inc. (ACLX) share was $50.02.

What is the 52-week high and low for Arcellx, Inc. Stock?
The 52-week high for Arcellx, Inc. Stock is $75.10 and the 52-week low is $30.78.

What is the market capitalization of Arcellx, Inc. Stock?
As of the Apr 30, 2024, the market capitalization of Arcellx, Inc. is 2.698B.

When is the next earnings date for Arcellx, Inc.?
The upcoming earnings date for Arcellx, Inc. is May 13, 2024.
Click to get the best stock tips daily for free!

About Arcellx, Inc.

Arcellx. Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It is also developing ACLX-001, an immunotherapeutic combination composed of ARC-T cells and bi-valent Sp... ACLX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT